The Use of High-Flow Nasal Oxygen in the ICU as a First-Line Therapy for Acute Hypoxemic Respiratory Failure Secondary to Coronavirus Disease 2019.

ABSTRACT:

Objectives

Limited evidence is available regarding the role of high-flow nasal oxygen in the management of acute hypoxemic respiratory failure secondary to coronavirus disease 2019. Our objective was to characterize outcomes associated with high-flow nasal oxygen use in critically ill adult patients with coronavirus disease 2019-associated acute hypoxemic respiratory failure.

Design

Observational cohort study between March 18, 2020, and June 3, 2020.

Setting

Nine ICUs at three university-affiliated hospitals in Philadelphia, PA.

Patients

Adult ICU patients with confirmed coronavirus disease 2019 infection admitted with acute hypoxemic respiratory failure.

Interventions

None.

Measurements and main results

Of 266 coronavirus disease 2019 ICU admissi

SUBMITTER: McDonough G 

PROVIDER: S-EPMC7571957 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature